BACKGROUND: To improve national influenza vaccination recommendations, additional data on influenza A and B virus circulation are needed. Here, we describe the circulation of influenza A and B in the Czech Republic during 16 seasons. METHODS: This was a retrospective analysis of data collected from the 2000-2001 to 2015-2016 influenza seasons by the Czech Republic national influenza surveillance network. Influenza was confirmed and viral isolates subtyped by virological assays followed by antigen detection or by reverse transcriptase-polymerase chain reaction. RESULTS: Of 16,940 samples collected, 5144 (30.4%) were influenza-positive. Influenza A represented 78.6% of positive cases overall and accounted for more than 55.0% of all influenza cases in every season, except for 2005-2006 (6.0%). Both A/H1N1 and A/H3N2 were detected in most seasons, except for 2001-2002 and 2003-2004 (only A/H3N2), and 2007-2008 and 2009-2010 (only A/H1N1). Influenza B represented 21.4% of positive cases overall (range, 0.0-94.0% per season). Both influenza B lineages were detected in three seasons, a single B lineage in 11, and no B strain in two. For the 11 seasons where influenza B accounted for ≥20% of positive cases, the dominant lineage was Yamagata in six and Victoria in four. In the remaining season, the two lineages co-circulated. For two seasons (2005-2006 and 2007-2008), the B lineage in the trivalent influenza vaccine did not match the dominant circulating B lineage. CONCLUSIONS: In the Czech Republic, during the 2000-2001 to 2015-2016 influenza seasons, influenza virus circulation varied considerably. Although influenza A accounted for the most cases in almost all seasons, influenza B made a substantial, sometimes dominant, contribution to influenza disease.

Department of Epidemiology and Biostatistics 3rd Medical Faculty Charles University Prague Czech Republic

Department of Infectious Diseases Epidemiology National Institute of Public Health Prague Czech Republic

National Reference Laboratory for Influenza and Other Respiratory Viruses National Institute of Public Health Prague Czech Republic

Sanofi Pasteur Lyon France

State Veterinary Institute Prague Czech Republic

Zobrazit více v PubMed

Council of the European Union Council Recommendation of 22 December 2009 on seasonal influenza vaccination. Off J Eur. Union. 2009;L 348:71–72.

Recommended procedure for vaccination against seasonal influenza in the Czech Republic [article in Czech]. Ministry of Health of the Czech Republic; 2011. http://www.mzcr.cz/dokumenty/doporuceny-postup-pro-ockovani-proti-sezonni-chripce_5194_1985_5.html. Accessed 23 Jan 2017.

European Centre for Disease Prevention and Control. Seasonal influenza vaccination in Europe. Overview of vaccination recommendations and coverage rates in the EU Member States for the 2012–13 influenza season. ECDC; 2015. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/Seasonal-influenza-vaccination-Europe-2012-13.pdf. Accessed 28 Sept 2016.

Prevention and control of influenza pandemics and annual epidemics. Resolution WHA56.19 of 28 May 2003. Geneva: World Health Organization; 2003. http://www.who.int/immunization/sage/1_WHA56_19_Prevention_and_control_of_influenza_pandemics.pdf. Accessed 9 Aug 2017.

Seasonal influenza vaccination programme, country profile: Czech Republic, 2012–2013 Season. European Centre for Disease Control and Prevention, Stockholm, Sweden. https://ecdc.europa.eu/sites/portal/files/media/en/publications/Report%20Assets/seasonal-vaccination-coverage-in-europe-2012-13/Seasonal-Influenza-Vaccination-Programme-Country-Profile-Czech-Republic.pdf (2015). Accessed 16 Jun 2016.

European Centre for Disease Prevention and Control. Seasonal influenza vaccination in Europe. Vaccination recommendations and coverage rates in the EU Member States for eight influenza seasons: 2007–2008 to 2014–2015. Stockholm: ECDC; 2017.

Palache A, Oriol-Mathieu V, Fino M, Xydia-Charmanta M. Seasonal influenza vaccine dose distribution in 195 countries (2004-2013): little progress in estimated global vaccination coverage. Vaccine. 2015;33(42):5598–5605. doi: 10.1016/j.vaccine.2015.08.082. PubMed DOI

Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother. 2012;8(1):81–88. doi: 10.4161/hv.8.1.17623. PubMed DOI PMC

Belshe RB. The need for quadrivalent vaccine against seasonal influenza. Vaccine. 2010;28(Suppl 4):D45–D53. doi: 10.1016/j.vaccine.2010.08.028. PubMed DOI

Hannoun C. The evolving history of influenza viruses and influenza vaccines. Expert Rev Vaccines. 2013;12(9):1085–1094. doi: 10.1586/14760584.2013.824709. PubMed DOI

Tisa V, Barberis I, Faccio V, Paganino C, Trucchi C, Martini M, et al. Quadrivalent influenza vaccine: a new opportunity to reduce the influenza burden. J Prev Med Hyg. 2016;57(1):E28–E33. PubMed PMC

Czech Republic Population Worldometers. http://www.worldometers.info/world-population/czech-republic-population/ (2018). Accessed 7 Sep 2018.

Kyncl J, Havlickova M, Jirincova H. Influenza attributable mortality in the Czech Republic. Poster P-488. In: Options IX for the Control of Influenza, 24–28 August 2016. Chicago: ISIRV; 2016.

Kovacs G, Kalo Z, Jahnz-Rozyk K, Kyncl J, Csohan A, Pistol A, et al. Medical and economic burden of influenza in the elderly population in central and eastern European countries. Hum Vaccin Immunother. 2014;10(2):428–440. doi: 10.4161/hv.26886. PubMed DOI PMC

World Health Organization. Influenza surveillance country profile - Czech Republic. WHO. http://www.euro.who.int/__data/assets/pdf_file/0003/272505/Country_profile_influenza_Czech-Republic_final_ENG_new-layout.pdf?ua=1 (2015). Accessed 10 Aug 2017.

World Health Organization. WHO Regional Office for Europe guidance for sentinel influenza surveillance in humans WHO Regional Office for Europe. http://www.euro.who.int/__data/assets/pdf_file/0020/90443/E92738.pdf (2011). Accessed 9 Aug 2017.

European Commission. Commission implementing decision of 8 August 2012 amending decision 2002/253/EC laying down case definitions for reporting communicable diseases to the community network under decision no 2119/98/EC of the European Parliament and of the council. Official J Eur Union. 2012;L262:1–56.

World Health Organization Global Influenza Surveillance Network. Manual for the laboratory diagnosis and virological surveillance of influenza. WHO. http://apps.who.int/iris/bitstream/10665/44518/1/9789241548090_eng.pdf (2011). Accessed 15 Sep 2017.

Nagy A, Cernikova L, Vitaskova E, Krivda V, Dan A, Dirbakova Z, et al. MeltMan: optimization, evaluation, and universal application of a qPCR system integrating the TaqMan qPCR and melting analysis into a single assay. PLoS One. 2016;11(3):e0151204. doi: 10.1371/journal.pone.0151204. PubMed DOI PMC

Daum LT, Canas LC, Arulanandam BP, Niemeyer D, Valdes JJ, Chambers JP. Real-time RT-PCR assays for type and subtype detection of influenza a and B viruses. Influenza Other Respir Viruses. 2007;1(4):167–175. doi: 10.1111/j.1750-2659.2007.00024.x. PubMed DOI PMC

Schweiger B, Zadow I, Heckler R, Timm H, Pauli G. Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples. J Clin Microbiol. 2000;38(4):1552–1558. PubMed PMC

Watzinger F, Suda M, Preuner S, Baumgartinger R, Ebner K, Baskova L, et al. Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J Clin Microbiol. 2004;42(11):5189–5198. doi: 10.1128/JCM.42.11.5189-5198.2004. PubMed DOI PMC

Caini S, Huang QS, Ciblak MA, Kusznierz G, Owen R, Wangchuk S, et al. Epidemiological and virological characteristics of influenza B: results of the global influenza B study. Influenza Other Respir Viruses. 2015;9(Suppl 1):3–12. doi: 10.1111/irv.12319. PubMed DOI PMC

Paul Glezen W, Schmier JK, Kuehn CM, Ryan KJ, Oxford J. The burden of influenza B: a structured literature review. Am J Public Health. 2013;103(3):e43–e51. doi: 10.2105/AJPH.2012.301137. PubMed DOI PMC

Puig-Barbera J, Burtseva E, Yu H, Cowling BJ, Badur S, Kyncl J, et al. Influenza epidemiology and influenza vaccine effectiveness during the 2014-2015 season: annual report from the global influenza hospital surveillance network. BMC Public Health. 2016;16(Suppl 1):757. doi: 10.1186/s12889-016-3378-1. PubMed DOI PMC

Mosnier A, Caini S, Daviaud I, Bensoussan JL, Stoll-Keller F, Bui TT, et al. Ten influenza seasons in France: distribution and timing of influenza a and B circulation, 2003-2013. BMC Infect Dis. 2015;15:357. doi: 10.1186/s12879-015-1056-z. PubMed DOI PMC

Heikkinen T, Ikonen N, Ziegler T. Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012. Clin Infect Dis. 2014;59(11):1519–1524. doi: 10.1093/cid/ciu664. PubMed DOI

World Health Organization Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec. 2012;47(87):461–476. PubMed

de Boer PT, van Maanen BM, Damm O, Ultsch B, Dolk FCK, Crepey P, et al. A systematic review of the health economic consequences of quadrivalent influenza vaccination. Expert Rev Pharmacoecon Outcomes Res. 2017;17(3):249–265. doi: 10.1080/14737167.2017.1343145. PubMed DOI

Uhart M, Bricout H, Clay E, Largeron N. Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe. Hum Vaccin Immunother. 2016;12(9):2259–2268. doi: 10.1080/21645515.2016.1180490. PubMed DOI PMC

Puig-Barbera J, Natividad-Sancho A, Trushakova S, Sominina A, Pisareva M, Ciblak MA, et al. Epidemiology of hospital admissions with influenza during the 2013/2014 northern hemisphere influenza season: results from the global influenza hospital surveillance network. PLoS One. 2016;11(5):e0154970. doi: 10.1371/journal.pone.0154970. PubMed DOI PMC

Puig-Barbera J, Tormos A, Sominina A, Burtseva E, Launay O, Ciblak MA, et al. First-year results of the global influenza hospital surveillance network: 2012-2013 northern hemisphere influenza season. BMC Public Health. 2014;14:564. doi: 10.1186/1471-2458-14-564. PubMed DOI PMC

Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347:f5061. doi: 10.1136/bmj.f5061. PubMed DOI PMC

Influenza-Related Deaths in the Czech Republic Over 21 Seasons

The Global Influenza Hospital Surveillance Network: A Multicountry Public Health Collaboration